Professor of Neurological Surgery, Oregon Hlth and Sci Univ
Neurosurgery
Dr. Edward A. Neuwelt, MD
|
|
Give Review
Edward A. Neuwelt works in the field of Neurosurgery. He graduated from University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is a top medical college. University of Colorado Denver School of Medicine is ranked 35/8 in Research/PrimaryCare. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Portland Monthly Magazine", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAANS)". Edward A. Neuwelt is a published doctor. He has 78 publications published. The most current publication "Primary CNS lymphoma: A landmark trial and the next steps." He is registered with Medicare and accepts Medicare payments.
Publications
- Primary CNS lymphoma: A landmark trial and the next steps.
- Diagnosis of pseudoprogression using MRI perfusion in patients with glioblastoma multiforme may predict improved survival.
- N-acetylcysteine chemoprotection without decreased cisplatin antiTumor efficacy in pediatric Tumor models.
- Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS Malignancies without prophylaxis.
- Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.
- Preservation of cognitive function in primary CNS lymphoma survivors a median of 12 years after enhanced chemotherapy delivery.
- Feasibility and potential role of ferumoxytol-enhanced neuroimaging in HIV-associated neurocognitive disorder.
- Preclinical high-dose acetaminophen with N-acetylcysteine rescue enhances the efficacy of cisplatin chemotherapy in atypical teratoid rhabdoid Tumors.
- Using iron oxide nanoparticles to diagnose CNS inflammatory Diseases and PCNSL.
- Inhibition of SUR1 Decreases the Vascular Permeability of Cerebral Metastases.
- Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.
- High-resolution steady-state cerebral blood volume maps in patients with central Nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle.
- The effect of alpha-v integrin inhibition on the malignant characteristics of Medulloblastoma.
- Immunologic privilege in the central nervous system and the blood-Brain barrier.
- Pseudoprogression of Glioblastoma after Chemo- and Radiation Therapy: Diagnosis by Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging with Fe...
- A 67 year old woman on Tumor necrosis factor- alpha inhibitor therapy presenting with neurological dysfunction.
- Targeting α(V)-integrins decreased metastasis and increased survival in a nude rat breast cancer Brain metastasis model.
- Dual contrast perfusion MRI in a single imaging session for assessment of pediatric Brain tumors.
- Comparative analysis of ferumoxytol and gadoteridol enhancement using t1- and t2-weighted MRI in neuroimaging.
- Improved Perfusion MR Imaging Assessment of IntraCerebral Tumor Blood Volume and Antiangiogenic Therapy Efficacy in a Rat Model with Ferumoxytol.
- The paradoxical effect of bevacizumab in the therapy of malignant Gliomas.
- Late occurrence of drop metastasis to the Spine in a case of esthesioneuroblastoma.
- Imaging and Therapy with Rituximab Anti-CD20 Immunotherapy in an Animal Model of Central Nervous System Lymphoma.
- MRI Using Ferumoxytol Improves the Visualization of Central Nervous System Vascular Malformations.
- Engaging neuroscience to advance translational research in Brain barrier biology.
- Temozolomide for corticotroph pituitary adenomas refractory to standard therapy.
- Potential for differentiation of pseudoprogression from true Tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ...
- Magnetic resonance imaging of intracranial Tumors: intra-patient comparison of gadoteridol and ferumoxytol.
- Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intraCerebral tumor models.
- Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: rat Cerebral glioma blood volume determination.
- Correlation of MRI sequences to assess progressive glioblastoma multiforme treated with bevacizumab.
- Treatment with bevacizumab plus carboplatin for recurrent malignant glioma.
- Critical need for international consensus on ototoxicity assessment criteria.
- Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central Nervous system in...
- Intra-arterial chemotherapy with osmotic blood-Brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.
- Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.
- Blood-Brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.
- FAPP2 gene downregulation increases Tumor cell sensitivity to Fas-induced apoptosis.
- Bevacizumab and carboplatin increase survival and asymptomatic Tumor volume in a glioma model.
- Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model.
- Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic Systemic fibrosis (...
- Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
- N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
- Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group rep...
- Intraarterial chemotherapy and osmotic blood-Brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
- Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity.
- siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic Stimuli.
- In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging.
- Can medical schools teach high school students to be scientists?
- Chemotherapy delivery issues in central Nervous system malignancy: a reality check.
- Characterization and magnetic resonance imaging of a rat model of human B-cell central Nervous system lymphoma.
- Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoAcoustic emissions.
- The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central Nervous system malignancy: a pilot study.
- Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-Brain-barrier disruption.
- International study on low-grade primary central Nervous system lymphoma.
- Implications of the blood-Brain barrier in primary central nervous system lymphoma.
- Distinguishing primary central Nervous system lymphoma from other central Nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches.
- Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.
- An exploratory study of ferumoxtran-10 nanoparticles as a blood-Brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions.
- Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat Brain and intracerebral tumor.
- Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
- Single-dose contrast agent for intraoperative MR imaging of intrinsic Brain tumors by using ferumoxtran-10.
- Program self-evaluation: the evolution of an injury prevention foundation.
- The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
- Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery.
- New frontiers in translational research in neuro-oncology and the blood-Brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.
- Herstatin, an autoinhibitor of the epidermal growth factor receptor family, blocks the intracranial growth of glioblastoma.
- Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat Brain tumor model.
- Mechanisms of disease: the blood-Brain barrier.
- Summary statement on primary central Nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.
- Advances in the understanding of the blood-Brain barrier in neuro-oncology.
- Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gl...
- Role of intravitreal methotrexate in the management of primary central Nervous system lymphoma with ocular involvement.
- Targeted delivery in primary and metastatic Brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
- Chemotherapeutic dose intensification for treatment of malignant Brain tumors: recent developments and future directions.
- Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial Tumors.
- Delivery of chemotherapeutics across the blood-Brain barrier: challenges and advances.
Schools
University Of Colorado School Of Medicine
University Tex Sw Med School
Baltimore Cancer Program
Procedures Preformed
- Epidural Block, Facet Blocks
- Spinal Nerve Block
- Ultrasound, Carotid
Conditions Treated
- Acoustic Neuroma
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- Brain Cancer
- View All
Doctors Specialties
- Neurosurgery
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Portland Monthly Magazine
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAANS)
Education
-
University of Maryland -
University of Colorado Denver School of Medicine
Drug Facts
| NPI NUMBER | 1114022837 | |
| NPPES Provider LastName | NEUWELT | |
| NPPES Provider FirstName | EDWARD | |
| NPPES Provider ZIPCode | 972393011 | |
| NPPES Provider State | OR | |
| Specialty Description | Neurosurgery | |
| Total Claim Count | 33.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114022837 |
| Last Name Of The Provider | NEUWELT |
| First Name Of The Provider | EDWARD |
| View All |
Similar Doctors
|
Dr. Darrell C. Brett, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas J. Rosenbaum, MD |
|
|
Dr. Kim A. Wayson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Silver, MD |
|
|
Dr. David E. Adler, MD |
|
|
Dr. Ahmed M. Raslan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keyvan Abtin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy D. Fields, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin S. Cetas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward W. Berkeley, MD |
|
|
Dr. Sunita V. Bhamidipaty, MD |
|
|
Dr. Kristoph Jahnke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick Vincent, MD
This Doctor is OpenDoctor Recommended.
|